恩舒尼盐酸盐
恩舒尼盐酸盐用途
恩舒尼盐酸盐名称
[ CAS 号 ]:
66794-74-9
[ 中文名 ]:
恩卡尼盐酸盐
[ 英文名 ]:
Encainide hydrochloride
[英文别名 ]:
- Encainide hydrochloride
- Encainide HCl
- Encainide hydrochloride (USAN)
- Enkaid
恩舒尼盐酸盐生物活性
[ 描述 ]:
[ 相关类别 ]:
[体内研究]
[参考文献]
恩舒尼盐酸盐物理化学性质
[ 密度 ]:
1.106g/cm3
[ 沸点 ]:
439.9ºC at 760mmHg
[ 分子式 ]:
C22H29ClN2O2
[ 分子量 ]:
388.93100
[ 闪点 ]:
219.8ºC
[ 精确质量 ]:
388.19200
[ PSA ]:
41.57000
[ LogP ]:
5.17730
[ 外观性状 ]:
粉末
[ 储存条件 ]:
2-8°C
恩舒尼盐酸盐MSDS
恩舒尼盐酸盐毒性和生态
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- CV5521500
- CHEMICAL NAME :
- Benzamide, 4-methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)pheny l)-, monohydrochloride, (+-)-
- CAS REGISTRY NUMBER :
- 66794-74-9
- LAST UPDATED :
- 199604
- DATA ITEMS CITED :
- 7
- MOLECULAR FORMULA :
- C22-H28-N2-O2.Cl-H
- MOLECULAR WEIGHT :
- 388.98
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 57 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NDADD8 New Drugs Annual: Cardiovascular Drugs. (New York, NY) V.1-2, 1983-84. For publisher information, see NCDREP. Volume(issue)/page/year: 1,93,1983
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 86 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NDADD8 New Drugs Annual: Cardiovascular Drugs. (New York, NY) V.1-2, 1983-84. For publisher information, see NCDREP. Volume(issue)/page/year: 1,93,1983
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 16 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NDADD8 New Drugs Annual: Cardiovascular Drugs. (New York, NY) V.1-2, 1983-84. For publisher information, see NCDREP. Volume(issue)/page/year: 1,93,1983
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 43 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NDADD8 New Drugs Annual: Cardiovascular Drugs. (New York, NY) V.1-2, 1983-84. For publisher information, see NCDREP. Volume(issue)/page/year: 1,93,1983
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 17 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NDADD8 New Drugs Annual: Cardiovascular Drugs. (New York, NY) V.1-2, 1983-84. For publisher information, see NCDREP. Volume(issue)/page/year: 1,93,1983
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Primate - monkey
- DOSE/DURATION :
- 8 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NDADD8 New Drugs Annual: Cardiovascular Drugs. (New York, NY) V.1-2, 1983-84. For publisher information, see NCDREP. Volume(issue)/page/year: 1,93,1983
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 5500 ug/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NDADD8 New Drugs Annual: Cardiovascular Drugs. (New York, NY) V.1-2, 1983-84. For publisher information, see NCDREP. Volume(issue)/page/year: 1,93,1983
恩舒尼盐酸盐安全信息
[ 符号 ]:
GHS06
[ 信号词 ]:
Danger
[ 危害声明 ]:
H301-H315-H319-H335
[ 警示性声明 ]:
P261-P301 + P310-P305 + P351 + P338
[ 个人防护装备 ]:
Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges
[ 危害码 (欧洲) ]:
T
[ 风险声明 (欧洲) ]:
25-36/37/38
[ 安全声明 (欧洲) ]:
26-45
[ 危险品运输编码 ]:
UN 2811 6.1/PG 3
[ RTECS号 ]:
CV5521500
恩舒尼盐酸盐文献
Clin. Pharm. 6(11) , 839-50, (1987)
The chemistry, electrophysiology, pharmacokinetics, clinical use and efficacy, adverse effects, drug interactions, and dosage of encainide hydrochloride and flecainide acetate are reviewed. Encainide ...
ST segment elevation induced by class IC antiarrhythmic agents: underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia.J. Cardiovasc. Electrophysiol. 9(11) , 1167-72, (1998)
Three patients in whom Class IC sodium channel blockers induced ST segment elevation in leads V1 through V3 are described. The underlying electrophysiologic mechanism, implications for drug-induced pr...
Adherence and arrhythmic mortality in the cardiac arrhythmia suppression trial (CAST).Ann. Epidemiol. 6(2) , 93-101, (1996)
Patient adherence to therapy is essential to assess treatment efficacy, particularly in clinical trials. Active treatment usually is expected to benefit patients. The healthy adherer effect, the assoc...
推荐生产厂家/供应商:
暂无推荐供应商。请联系客服获知如何成为推荐供应商。
热门化合物
【恩舒尼盐酸盐】化源网提供恩舒尼盐酸盐CAS号66794-74-9,恩舒尼盐酸盐MSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询恩舒尼盐酸盐上化源网,专业又轻松。>>电脑版:恩舒尼盐酸盐
标题:恩舒尼盐酸盐_MSDS_用途_密度_恩舒尼盐酸盐CAS号【66794-74-9】_化源网 地址:https://m.chemsrc.com/mip/cas/66794-74-9_831856.html